We next explored the molecular mechanisms by which CRABP2 promotes CRC progression by performing immunoprecipitation followed by mass spectrometry to identify proteins that interact with CRABP2 in DLD‐1 cells (Figure 2A). This evidence concerns the gene CRABP2 and colorectal carcinoma.